“…(2018) [ 28 ] and Rojas et al. (2021) [ 29 ] reported similar results in OPRA-treated patients in the UK (n = 13) and Chile (n = 21), respectively, as in the Swedish OPRA study, i.e., robust and statistically significant improvements in all four Q-TFA scores and in part of the SF-36 scores after five years. Similarly, Reetz et al.…”